The UK DRI Care Research & Technology Centre brings together scientists from a range of backgrounds, including medicine, engineering, computer science and synthetic biology to develop a range of innovative ‘smart’ technologies – from artificial intelligence to sleep monitoring – to enable people affected by dementia to live safely and independently in their own homes for as long as possible.
Learn more
We are delighted to announce the appointment of Prof Caleb Webber as UK DRI Director of Informatics. In this new role, Prof Webber will be responsible for developing and implementing an Institute-wide strategy to harness the power of data resources and tools in our mission to find new treatments and technologies for dementia.
Read more
A study led by Dr Edward Avezov (UK DRI at Cambridge) has uncovered a new mechanism that might help prevent the build-up of tangles of proteins commonly seen in dementia.
Read more
Co-founded by Prof Chris Shaw (UK DRI at King's), AviadoBio will use a patented gene therapy platform to develop innovative treatments for people living with neurodegenerative diseases. If successful, these treatments have the potential to permanently correct faulty genes, transforming the lives of individuals affected.
Read more
The Dementia UK Ecosystem (DUKE) brings together leaders from the UK DRI, Dementias Platform UK, the National Institute for Health Research, the pharmaceutical industry, and funders to create a cohesive community, coordinating efforts to accelerate progress in tackling dementia.
Read more
Group Leader Dr Nir Grossman (UK DRI at Imperial) is leading a new trial using deep electrical currents applied to the brain of people living with Alzheimer's disease. The team are recruiting participants over the next year.
Read more
We have a clearly defined vision at the UK DRI to develop effective therapeutics, diagnostics and technologies for people living with dementia. Alongside building our disease knowledge over the coming years, we will also make progress in translating these discoveries into the clinic.
Translation and innovation
We accelerate, innovate, deepen and broaden discovery science in dementia, with the goal of filling the huge knowledge gap in this field. We exist to bring forward the day when research benefits people living with and those at risk of dementia.
Read our science vision
Our efforts to increase the diversity of our team, ensure inclusion and promote equality of opportunity, align with our vision for the UK DRI’s Institute culture and identity as a world-leader in dementia research.
Equity, Diversity and Inclusion
We study a range of neurodegenerative disorders that cause dementia. Many of them share fundamental disease mechanisms and characteristics, and greater understanding gained in one can often benefit others. To ensure we capitalise on diverse expertise, approaches and perspectives, we have established cross-centre themes.
Research themes
